Outlook Therapeutics (OTLK) Prepaid Assets (2015 - 2026)
Outlook Therapeutics (OTLK) posted quarterly Prepaid Assets of $7.1 million for Q1 2026, up 6.71% year-over-year from $6.6 million in Q1 2025, and up 44.26% quarter-over-quarter from $4.9 million in Q4 2025.
Outlook Therapeutics (OTLK) Prepaid Assets (2015 - 2026) Analysis & Trends
Outlook Therapeutics (OTLK) has reported Prepaid Assets for 12 consecutive years, with $7.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets rose 6.71% year-over-year to $7.1 million; the TTM figure through Mar 2026 stood at $7.1 million (up 6.71% YoY), while the FY2025 annual figure was $4.5 million, down 64.15% from the prior year.
- Prepaid Assets improved to $7.1 million in Q1 2026 per OTLK's latest filing, from $4.9 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $13.6 million in Q2 2024 and bottomed at $4.5 million in Q3 2025.
- Historically, Prepaid Assets has averaged $8.7 million across 5 years, with a median of $9.3 million in 2023.
- Annual changes were most pronounced in 2024 — Prepaid Assets soared 64.6% — and 2025, when it plunged 64.15%.
- Outlook Therapeutics' Prepaid Assets stood at $9.3 million in 2022, then climbed by 7.47% to $10.0 million in 2023, then slumped by 31.67% to $6.9 million in 2024, then slipped by 28.28% to $4.9 million in 2025, then soared by 44.26% to $7.1 million in 2026.
- Business Quant data shows OTLK's Prepaid Assets at $7.1 million in Q1 2026, $4.9 million in Q4 2025, and $4.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Outlook Therapeutics | 88.50 Mn | 77.26 Mn | -8,265.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.09 Mn |
| Dec 31, 2025 | 4.92 Mn |
| Sep 30, 2025 | 4.48 Mn |
| Jun 30, 2025 | 6.32 Mn |
| Mar 31, 2025 | 6.65 Mn |
| Dec 31, 2024 | 6.86 Mn |
| Sep 30, 2024 | 12.49 Mn |
| Jun 30, 2024 | 13.59 Mn |
| Mar 31, 2024 | 10.56 Mn |
| Dec 31, 2023 | 10.03 Mn |
| Sep 30, 2023 | 7.59 Mn |
| Jun 30, 2023 | 9.31 Mn |
| Mar 31, 2023 | 9.42 Mn |
| Dec 31, 2022 | 9.34 Mn |
| Sep 30, 2022 | 10.12 Mn |
| Jun 30, 2022 | 11.49 Mn |
| Mar 31, 2022 | 8.12 Mn |
| Dec 31, 2021 | 7.32 Mn |
| Sep 30, 2021 | 7.03 Mn |
| Jun 30, 2021 | 12.21 Mn |